Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
Bates Jonathan
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-15+5,500→ 5,500 totalExercise: $14.27Exp: 2027-06-14→ Common Stock (5,500 underlying)
Footnotes (1)
- [F1]Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 15, 2017, the date of the Issuer's 2017 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.